Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.
about
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificityHow specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depthIsolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusAuthentic and chimeric full-length genomic cDNA clones of bovine viral diarrhea virus that yield infectious transcriptsThe structural basis of repertoire shift in an immune response to phosphocholineX-ray crystal structure of an anti-Buckminsterfullerene antibody Fab fragment: Biomolecular recognition of C60Immunoglobulin heavy chain diversity in Pteropid bats: evidence for a diverse and highly specific antigen binding repertoireMF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition.Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses.A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies.B-cell fate decisions following influenza virus infection.A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus.Neonatal immunity and somatic mutation.Antibody responses during hepatitis B viral infection.What is missing in immunology to understand immunity?Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsidA novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Kinetics of association of anti-lysozyme monoclonal antibody D44.1 and hen-egg lysozyme.The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.Kinetic and affinity limits on antibodies produced during immune responses.Uncertainties - discrepancies in immunology.High preexisting serological antibody levels correlate with diversification of the influenza vaccine responseIntranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge.Protective B cell responses to flu--no fluke!Enhanced HIV-1 neutralization by antibody heteroligationPreferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigeneA Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation.Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.Human antibodies from transgenic animals.Induction of long-lived germinal centers associated with persisting antigen after viral infection.Protective T cell-independent antiviral antibody responses are dependent on complement.Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodiesVisualizing the effects of antigen affinity on T-dependent B-cell differentiation.Progress and prospects for L2-based human papillomavirus vaccinesStructural mechanism for affinity maturation of an anti-lysozyme antibodyInitiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages
P2860
Q26779753-991F2EB8-3452-4313-9E15-B549E30DEB5FQ27026728-70FABD0A-2981-4439-A6DF-83DB0D15CAACQ27473288-D661E4A8-520F-4CC7-996A-27D5D41FA464Q27480772-45F75FD3-2A96-468A-91FB-574F35AAE2DDQ27624954-883D58ED-77BA-4508-8268-549D63206D28Q27627507-7D152F23-4F4F-4ABC-BB2F-9C6B2EB2C5B7Q28751452-81AA5AEF-2509-4575-BE97-E2DB0484F321Q30403361-679ED8D4-0920-4CC0-B7F9-05CE040363F8Q30476133-DE80D176-325E-414C-B51C-53639E24399DQ30708822-2BF58192-52E5-41F8-8B1E-5C3328EB782BQ30717070-52385DA0-29E9-4F58-A123-4D3EB7BD0D46Q33757105-EB6684CD-0E4B-4C96-86AC-391234FA906BQ33825684-C40C5F44-0816-4F7E-8496-756C6BDF7261Q33891076-C3D5EAF7-623E-4D11-A567-1A6A07E36E9DQ33981600-E619B639-1DB6-426D-B824-B430AA998972Q34023421-F93EAE47-EBDC-44F6-8836-7199CDE611ECQ34036827-E1DC54BC-30C5-4C86-8E55-9A54A5F749F4Q34172295-F9FE36C5-BE4F-4718-88F8-F58B9B21205EQ34174497-F0F816DF-87F2-4B73-928F-730888DDFED9Q34399656-6DD3651E-CC69-49CD-8392-FF0745B2A8DFQ34598643-9955B908-0C50-4541-91BA-0082F35F28CCQ34792441-B983D4B9-87E5-47EB-8F65-6A6947B52DB8Q35110980-682DA97A-02D5-4541-8025-C0171ACD526EQ35149731-5C820BDD-5EF5-43F7-86FC-9424582526CAQ35158499-6E38AB67-78F1-4888-974B-5B4C991E5E3CQ35735385-755B6FA9-373D-4AF0-A5B8-8B93672C8CEAQ35880124-58CA3078-DA59-45FF-9023-5F4F7EA0EDC3Q35921799-7B864CD7-EA6E-4053-AB47-65FD1F34EB42Q36228608-86E534F0-4D47-4387-A6E7-60C55D2D43B5Q36228781-B433C254-0F66-4F6D-927F-AF2089B22794Q36252986-2E5B9B2A-F133-4840-94CC-9315D72A7A5FQ36366635-71E17C0B-7DB6-4546-BDC9-ECE541E17942Q36375462-29270758-5FC2-4CC1-8E62-905CA7601F30Q36400299-E9326D13-7E6C-455D-96D3-3E7E08E4E877Q36480943-C4A8BF6E-ECF6-4021-B6DA-3CEA3D19FB09Q36689886-9C345DAB-ACEE-4633-9FA7-E47826E78BACQ37008253-C71B3048-DD27-492F-9DF0-4459CF465E97Q37014047-F0FD3CAE-8E62-4AC1-8CF9-55A1EFBC0293Q37074120-30CF0A7E-0747-4D8F-944D-E2850072CA66Q37221575-A02D0901-909B-438D-9CD9-C847303C8C9D
P2860
Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Early high-affinity neutralizi ...... rall improvements of affinity.
@ast
Early high-affinity neutralizi ...... rall improvements of affinity.
@en
Early high-affinity neutralizi ...... rall improvements of affinity.
@nl
type
label
Early high-affinity neutralizi ...... rall improvements of affinity.
@ast
Early high-affinity neutralizi ...... rall improvements of affinity.
@en
Early high-affinity neutralizi ...... rall improvements of affinity.
@nl
prefLabel
Early high-affinity neutralizi ...... rall improvements of affinity.
@ast
Early high-affinity neutralizi ...... rall improvements of affinity.
@en
Early high-affinity neutralizi ...... rall improvements of affinity.
@nl
P2093
P2860
P356
P1476
Early high-affinity neutralizi ...... rall improvements of affinity.
@en
P2093
Bachmann MF
Hengartner H
Zinkernagel RM
P2860
P304
P356
10.1073/PNAS.92.5.1257
P407
P577
1995-02-01T00:00:00Z